Patient related characteristics |
Patient related
characteristics |
Mean Age (± SD) |
10.5 (± 3.2) years |
Mean duration between diagnosis and enrolment (± SD) |
5.0 (±
2.8) years |
Age distribution
6-9 years
10-13 years
14-17 years
|
N (%)
34 (48)
18 (26)
18 (26)
|
Gender
Male
Female
|
54 (77)
16 (23)
|
Socioeconomic strata
Upper Strata
Middle Strata
Lower Strata
|
14 (20)
32 (45)
24 (35)
|
Parental education
<Primary school education
>Primary school education
|
36 (25)
104 (75)
|
Birth order
<=2
>2
|
56 (80)
14 (20)
|
Family Type
Nuclear
Multi Generational
|
30 (43)
40 (57)
|
Disease and Treatment Related |
Disease and Treatment
Related |
CNS disease at diagnosis
Positive
Negative
|
8 (11)
62 (89)
|
Radiation received
Therapeutic (1800 cGy)
Prophylactic (1260 cGy)
|
8 (11)
62 (89)
|
Chemotherapy what is protocol A and B
Protocol A:
IV Methotrexate at 0 mg/m2
Intrathecal (IT) methotrexate only
Prednisolone 4040 mg/m2
Dexamethasone 40 mg/m2
IV Cytarabine 16400 mg/m2
Protocol B:
IV methotrexate at 5800 mg/m2
Triple IT
Prednisolone 2880 mg/m2
Dexamethasone 670 mg/m2
IV Cytarabine 30400 mg/m2
|
58 (83)
12 (17)
|